The rising popularity in GLP-1 agonists for diabetes has led to a debate about formats: skin-applied devices versus capsules. Usually , GLP-1 therapies were only available in pill form, but the https://andrewsfup528459.diowebhost.com/96124569/glp-1-skin-applications-vs-oral-medications-what-suitable-for-the-patient